IMDX vs LCID · rev $271.0K vs rev $687.8M
Insight Molecular Diagnostics Inc. (IMDX) versus Lucid Group Inc (LCID) — a side-by-side from cached financials, not a winner call.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Lucid Group Inc (LCID) is a auto manufacturers company listed on NASDAQ. It is led by Peter Rawlinson.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
Latest reported LCID revenue for 2026-06-30 was $687.8M. Net income was -$2.06B. LCID currently screens at market cap $2.04B.
IMDX currently screens at market cap $0. LCID currently screens at market cap $2.04B.
Not investment advice. Open the IMDX and LCID stock pages for the full models.
Not investment advice.